Inoveon
Launches World-Class Digital Image Evaluation Center
Inoveon
Evaluation Center is Nation's First Dedicated Digital
Reading Center
For
Immediate Release: October 3, 2000
Media
Contact: Lloyd Hildebrand, Chief Medical Officer |
1.405.271.9025 | lloyd-hildebrand@inoveon.com
OKLAHOMA CITY - Inoveon, an E-health company marketing
digital disease detection and tracking technology over the
Internet, today announced the opening of the Inoveon
Evaluation Center in Nashville, TN., a world-class digital
imaging reading center currently specializing in ophthalmic
imaging.
"The Inoveon Evaluation Center, combined with Inoveon's Internet digital data transfer system, positions us for growth on a number of fronts; reading ophthalmic images for medical diagnosis and as a pivotal platform for clinical trials," said Dr. P. Lloyd Hildebrand, M.D., Inoveon co-founder and chief executive officer.
The Inoveon Evaluation Center has engaged the entire administrative and senior reading team of experts from the prestigious former Vanderbilt Ophthalmic Reading Center. The Inoveon senior reading team has more than 30 years of combined experience evaluating images of the eye. Thomas Leonard-Martin Ph.D., M.P.H., former Director of the Vanderbilt operation, heads up the team as Director of Evaluation Services, bringing 15 years of experience in the evaluation of ophthalmic photographs and images. Dr. Leonard-Martin has worked in ophthalmic research for over 20 years.
The Inoveon Evaluation Center will continue the staff's work reading film for patient care and clinical trials of diabetic retinopathy, macular degeneration, corneal opacities and pediatric screening photography for amblyopia (or lazy eye), while leading in the development of digital imaging procedures for all of these conditions. Inoveon is actively expanding its fully digital imaging capability from the realm of patient care into that of clinical research and trials. "Digital images are a major breakthrough in this field of traditional film-based imaging. Digital imaging gives us the capability of offering companies and medical institutions the quality of film, with the speed, cost-efficiencies and time-savings of digital images that can be transferred through Inoveon's unique Internet-based technology," said Leonard- Martin.
The Inoveon Evaluation Center is a crucial element in Inoveon's 3DT (Digital Disease Detection and Tracking) system now being used in a number of commercial applications. 3DT uses the Internet to rapidly transport high resolution images taken of a diabetic's retina in a primary care setting to the Inoveon Evaluation Center where the evaluation team examines the multiple images for signs of diabetic retinopathy. An evaluation of the retinal images is returned to the primary care professional over the Internet in 48 hours so that the patient's own physician can offer diagnosis and treatment options.
"The Inoveon Evaluation Center is unsurpassed in the experts, experience and technology they bring to the digital world of reading ophthalmic images," concluded Hildebrand.
Inoveon was founded in 1998 to improve clinical disease management by utilizing advanced digital Internet technologies. The company develops and markets digital disease detection and tracking services to primary care, specialty care and ophthalmology healthcare providers. Wesley Jessen VisionCare, Inc., (NASDAQ:WJCO) is a leading investor in Inoveon Corp. and has exclusive marketing rights of Inoveon services in the optometric field. Inoveon's Internet data transfer system also has application in other chronic diseases such as cardiology, asthma, breast cancer and more.